RecruitingNCT06711575

Model-informed Individualized Treatment of Anti-Infective Drugs in Patients With Spinal Infections

Sponsor

Shandong University

Enrollment

300 participants

Start Date

Oct 12, 2024

Study Type

OBSERVATIONAL

Conditions

Infectious Diseases of Spine

Summary

The purpose of this study is to describe the population pharmacokinetic characteristics in patients with suspected/confirmed spinal infections who are undergoing anti-infective drug therapy, and to evaluate effectiveness and safety of these drugs.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Anti-Infective Drugs for people with infectious diseases of spine. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAnti-Infective Drugs

Anti-infective drugs are administered using the traditional clinical dosing regimen, with no interventions.

Locations(1)

Shandong Public Health Clinical Center

Jinan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06711575